Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001437749-25-018573
Filing Date
2025-05-27
Accepted
2025-05-27 20:30:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3538
  Complete submission text file 0001437749-25-018573.txt   5299
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Subject) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35285 | Film No.: 25990615
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VAXART, INC. 170 HARBOR WAY, STE. 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Lee Phillip E (Reporting) CIK: 0001959565 (see all company filings)

Type: 144